TNF and Crohn disease: Current research primarily focuses on its efficacy and safety, positioning ustekinumab as an alternative treatment option for Crohn's disease following the failure of traditional immunosuppressive therapy or tumor necrosis factor-alpha (TNF-α) antagonist treatment (12).